Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

عرض إصدارات أخرى (1)

Background: The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase 3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria and severe malaria. To ascertain variations in vaccine efficacy according to covariates such as transmissio...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Bejon, P, White, M, Olotu, A, Bojang, K, Lusingu, J, Salim, N, Otsyula, N, Agnandji, S, Asante, K, Owusu-Agyei, S, Abdulla, S, Ghani, A
التنسيق:	Journal article
منشور في:	2013

مواد مشابهة

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
حسب: Bejon, P, وآخرون
منشور في: (2013)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
حسب: White, M, وآخرون
منشور في: (2014)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
حسب: Warimwe, G, وآخرون
منشور في: (2013)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
حسب: Olotu, A, وآخرون
منشور في: (2010)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
حسب: Bejon, P, وآخرون
منشور في: (2009)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
حسب: Olotu, A, وآخرون
منشور في: (2013)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
حسب: Olotu, A, وآخرون
منشور في: (2016)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
حسب: White, M, وآخرون
منشور في: (2013)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
حسب: Bejon, P, وآخرون
منشور في: (2008)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
حسب: Stephaney Gyaase, وآخرون
منشور في: (2021-01-01)

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
حسب: Bejon, P, وآخرون
منشور في: (2009)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
حسب: Bejon, P, وآخرون
منشور في: (2011)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
حسب: Ndungu, F, وآخرون
منشور في: (2012)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
حسب: Olotu, A, وآخرون
منشور في: (2014)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
حسب: Vekemans, J, وآخرون
منشور في: (2011)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
حسب: Olotu, A, وآخرون
منشور في: (2011)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
حسب: Lusingu, J, وآخرون
منشور في: (2010)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
حسب: Duncan, C, وآخرون
منشور في: (2011)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.
حسب: Michael T White, وآخرون
منشور في: (2013-01-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
حسب: Bejon, P, وآخرون
منشور في: (2008)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
حسب: Agnandji, S, وآخرون
منشور في: (2012)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
حسب: Horowitz, A, وآخرون
منشور في: (2012)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
حسب: Daniel Ansong, وآخرون
منشور في: (2011-04-01)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
حسب: Agnandji, S, وآخرون
منشور في: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
حسب: Lievens, M, وآخرون
منشور في: (2011)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
حسب: Ndungu, F, وآخرون
منشور في: (2019)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
حسب: Seth Owusu-Agyei, وآخرون
منشور في: (2010-01-01)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
حسب: Carlota Dobaño, وآخرون
منشور في: (2019-05-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
حسب: Seth Owusu-Agyei, وآخرون
منشور في: (2009-10-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
حسب: Ally Olotu, وآخرون
منشور في: (2011-01-01)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
حسب: Ally Olotu, وآخرون
منشور في: (2014-01-01)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
حسب: Otieno, L, وآخرون
منشور في: (2019)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
حسب: Guerra Mendoza, Y, وآخرون
منشور في: (2019)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
حسب: Vekemans Johan, وآخرون
منشور في: (2011-08-01)

RTS,S: the first malaria vaccine
حسب: Fidel Zavala
منشور في: (2022-01-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
حسب: John N Waitumbi, وآخرون
منشور في: (2009-11-01)

What is the efficacy of the RTS,S malaria vaccine?
حسب: Duncan, C, وآخرون
منشور في: (2011)

What is the efficacy of the RTS,S malaria vaccine?
حسب: Duncan, C, وآخرون
منشور في: (2011)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
حسب: John Lusingu, وآخرون
منشور في: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
حسب: John Lusingu, وآخرون
منشور في: (2010-11-01)